- According to estimates from 14 analysts, Charles River Laboratories International, Inc. stock's average price target has risen from $234.64 to $237.79, with forecasts ranging from $180 to $265 per share
- Based on the Jul. 10 closing price, the updated target implies approximately 2% potential upside
- Consensus rating remains at “Buy” across 20 covering analysts, with 15 Buys, 4 Holds and 1 Sells
Explore more price target data and ratings for Charles River Laboratories International, Inc. on the , and track all previous and future analyst recommendations for Charles River Laboratories International, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.